CHRNA7 haplotypes are associated with impaired attention in euthymic bipolar disorder

Journal of Affective Disorders

Volumn 133, Issue 1-2, 2011, Pages 340-345

  Ancin I ^a   Cabranes, J A ^a,b   Santos, J L ^c   Sanchez Morla E ^c   Vazquez Alvarez B ^a   Rodriguez Moya L ^a   Pousada Casal, A ^d   Fernandez C ^a   Aparicio, A ^c   Barabash, A ^a,b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Virgen de la Luz Hospital   (Spain)

^d Ibermutuamur Corporación Mutua   (Spain)

Author keywords

Bipolar disorder; CHRNA7; Endophenotype; Genetics; Haplotype; Sustained attention deficit

Indexed keywords

BUNGAROTOXIN RECEPTOR;

ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COGNITION; CONTINUOUS PERFORMANCE TEST; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EUTHYMIC BIPOLAR DISORDER; FEMALE; GENE DUPLICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE;

ADULT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CYCLOTHYMIC DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, NICOTINIC;

EID: 80051653617     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.04.008     Document Type: Article

References (48)

1. I. Ancin, A. Barabash, B. Vazquez-Alvarez, J.L. Santos, E. Sanchez-Morla, J.L. Martinez, A. Aparicio, J.C. Pelaez, and J.A. Diaz Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia Psychiatr. Genet. 20 2010 289 297
2. I. Ancin, J.L. Santos, C. Teijeira, E.M. Sanchez-Morla, M.J. Bescos, I. Argudo, S. Torrijos, B. Vazquez-Alvarez, I. De LV, J.J. Lopez-Ibor, A. Barabash, and J.A. Cabranes-Diaz Sustained attention as a potential endophenotype for bipolar disorder Acta Psychiatr. Scand. 122 2010 235 245
3. S. Barak, M. Arad, L.A. De, M.D. Black, G. Griebel, and I. Weiner Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia Neuropsychopharmacology 34 2009 1753 1763
4. E. Bora, M. Yucel, and C. Pantelis Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives J. Affect. Disord. 113 2009 1 20
5. C.R. Breese, M.J. Marks, J. Logel, C.E. Adams, B. Sullivan, A.C. Collins, and S. Leonard Effect of smoking history on [3H]nicotine binding in human postmortem brain J. Pharmacol. Exp. Ther. 282 1997 7 13 (Pubitemid 27425521)
6. J.J. Buccafusco, and A.V. Terry Jr. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists Biochem. Pharmacol. 78 2009 852 862
7. W.J. Chen, C.K. Hsiao, L.L. Hsiao, and H.G. Hwu Performance of the Continuous Performance Test among community samples Schizophr. Bull. 24 1998 163 174 (Pubitemid 28128497)
8. P. Chomczynski, K. Mackey, R. Drews, and W. Wilfinger DNAzol: a reagent for the rapid isolation of genomic DNA Biotechniques 22 1997 550 553 (Pubitemid 27131054)
9. T.J. Crow A Darwinian approach to the origins of psychosis Br. J. Psychiatry 167 1995 12 25 (Pubitemid 26124569)
10. C.M. Cullum, J.G. Harris, M.C. Waldo, E. Smernoff, A. Madison, H.T. Nagamoto, J. Griffith, L.E. Adler, and R. Freedman Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia Schizophr. Res. 10 1993 131 141 (Pubitemid 23273366)
11. V. De Luca, O. Likhodi, H.H. Van Tol, J.L. Kennedy, and A.H. Wong Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia Acta Psychiatr. Scand. 114 2006 211 215 (Pubitemid 44186251)
12. E.L. Dempster, T. Toulopoulou, C. McDonald, E. Bramon, M. Walshe, H. Wickham, P.C. Sham, R.M. Murray, and D.A. Collier Episodic memory performance predicted by the 2 bp deletion in exon 6 of the "alpha 7-like" nicotinic receptor subunit gene Am. J. Psychiatry 163 2006 1832 1834 (Pubitemid 44522496)
13. R.J. Erwin, B.I. Turetsky, P. Moberg, R.C. Gur, and R.E. Gur P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention Schizophr. Res. 33 1998 157 167 (Pubitemid 28446540)
14. C. Fernandes, E. Hoyle, E. Dempster, L.C. Schalkwyk, and D.A. Collier Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory Genes Brain Behav. 5 2006 433 440 (Pubitemid 44199563)
15. I.I. Gottesman, and T.D. Gould The endophenotype concept in psychiatry: etymology and strategic intentions Am. J. Psychiatry 160 2003 636 645 (Pubitemid 41079594)
16. M. Hajos, R.S. Hurst, W.E. Hoffmann, M. Krause, T.M. Wall, N.R. Higdon, and V.E. Groppi The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats J. Pharmacol. Exp. Ther. 312 2005 1213 1222 (Pubitemid 40293783)
17. G. Hasler, W.C. Drevets, T.D. Gould, I.I. Gottesman, and H.K. Manji Toward constructing an endophenotype strategy for bipolar disorders Biol. Psychiatry 60 2006 93 105 (Pubitemid 44026591)
18. T.A. Hauser, A. Kucinski, K.G. Jordan, G.J. Gatto, S.R. Wersinger, R.A. Hesse, E.K. Stachowiak, M.K. Stachowiak, R.L. Papke, P.M. Lippiello, and M. Bencherif TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia Biochem. Pharmacol. 78 2009 803 812
19. S.N. Haydar, C. Ghiron, L. Bettinetti, H. Bothmann, T.A. Comery, J. Dunlop, R.S. La, I. Micco, M. Pollastrini, J. Quinn, R. Roncarati, C. Scali, M. Valacchi, M. Varrone, and R. Zanaletti SAR and biological evaluation of SEN12333/WAY-317538: novel alpha 7 nicotinic acetylcholine receptor agonist Bioorg. Med. Chem. 17 2009 5247 5258
20. C.J. Hong, I.C. Lai, L.L. Liou, and S.J. Tsai Association study of the human partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant with bipolar disorder Neurosci. Lett. 355 2004 69 72
21. E. Houy, G. Raux, F. Thibaut, A. Belmont, C. Demily, G. Allio, S. Haouzir, G. Fouldrin, M. Petit, T. Frebourg, and D. Campion The promoter - 194C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit Mol. Psychiatry 9 2004 320 322 (Pubitemid 38496725)
22. E. Hoyle, R.F. Genn, C. Fernandes, and I.P. Stolerman Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task Psychopharmacology (Berl) 189 2006 211 223 (Pubitemid 44691543)
23. P.C. Hsieh, C.L. Chu, Y.K. Yang, Y.C. Yang, T.L. Yeh, I.H. Lee, and P.S. Chen Norms of performance of sustained attention among a community sample: Continuous Performance Test study Psychiatry Clin. Neurosci. 59 2005 170 176 (Pubitemid 40524952)
24. S. Jones, S. Sudweeks, and J.L. Yakel Nicotinic receptors in the brain: correlating physiology with function Trends Neurosci. 22 1999 555 561
25. H. Kitagawa, T. Takenouchi, R. Azuma, K.A. Wesnes, W.G. Kramer, D.E. Clody, and A.L. Burnett Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers Neuropsychopharmacology 28 2003 542 551
26. K. Koike, K. Hashimoto, N. Takai, E. Shimizu, N. Komatsu, H. Watanabe, M. Nakazato, N. Okamura, K.E. Stevens, R. Freedman, and M. Iyo Tropisetron improves deficits in auditory P50 suppression in schizophrenia Schizophr. Res. 76 2005 67 72 (Pubitemid 40824561)
27. S. Leonard, J. Gault, J. Hopkins, J. Logel, R. Vianzon, M. Short, C. Drebing, R. Berger, D. Venn, P. Sirota, G. Zerbe, A. Olincy, R.G. Ross, L.E. Adler, and R. Freedman Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia Arch. Gen. Psychiatry 59 2002 1085 1096 (Pubitemid 35424018)
28. M. Lezak Neuropsychological Assessment 2004 OxfordUniversity Press New York
29. Mackey, K., Williams, P., Seim, S., Chomczynski, P., 1996. The use of DNAzol for the rapid isolation of genomic DNA from whole blood. Biomedical Products Supplement:13-15.
30. L.F. Martin, W.R. Kem, and R. Freedman Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia Psychopharmacology (Berl) 174 2004 54 64 (Pubitemid 38925091)
31. L.F. Martin, S. Leonard, M.H. Hall, J.R. Tregellas, R. Freedman, and A. Olincy Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 2007 611 614 (Pubitemid 47077144)
32. S. Mexal, R. Berger, J. Logel, R.G. Ross, R. Freedman, and S. Leonard Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers J. Mol. Neurosci. 40 2010 185 195
33. K.H. Nuechterlein, R. Parasuraman, and Q. Jiang Visual sustained attention: image degradation produces rapid sensitivity decrement over time Science 220 1983 327 329 (Pubitemid 13118492)
34. K.H. Nuechterlein, M.E. Dawson, J. Ventura, D. Miklowitz, and G. Konishi Information-processing anomalies in the early course of schizophrenia and bipolar disorder Schizophr. Res. 5 1991 195 196
35. Nuechterlein, K.H., Asarnow, R.F., 1999. Degraded Stimulus Continuous Performance Test (DS-CPT) Program for IBM-Compatible Microcomputers. Version 8.12. [8.12]. 1999. Los Angeles, CA. Ref Type: Computer Program.
36. A. Olincy, J.G. Harris, L.L. Johnson, V. Pender, S. Kongs, D. Allensworth, J. Ellis, G.O. Zerbe, S. Leonard, K.E. Stevens, J.O. Stevens, L. Martin, L.E. Adler, F. Soti, W.R. Kem, and R. Freedman Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia Arch. Gen. Psychiatry 63 2006 630 638 (Pubitemid 43848294)
37. D. Potter, A. Summerfelt, J. Gold, and R.W. Buchanan Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia Schizophr. Bull. 32 2006 692 700 (Pubitemid 44412856)
38. S. Quraishi, and S. Frangou Neuropsychology of bipolar disorder: a review J. Affect. Disord. 72 2002 209 226 (Pubitemid 35351281)
39. A. Rigbi, K. Kanyas, A. Yakir, L. Greenbaum, Y. Pollak, E. Ben-Asher, D. Lancet, S. Kertzman, and B. Lerer Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function Genes Brain Behav. 7 2008 164 172 (Pubitemid 351342191)
40. E.M. Sanchez-Morla Tesis Doctoral: Evaluación Neuropsicoló gica en Pacientes Bipolares Eutímicos: un estudio comparativo con pacientes esquizofrénicos estabilizados 2006 Universidad Autónoma Madrid Ref Type: Thesis/Dissertation
41. D.J. Schaid, C.M. Rowland, D.E. Tines, R.M. Jacobson, and G.A. Poland Score tests for association between traits and haplotypes when linkage phase is ambiguous Am. J. Hum. Genet. 70 2002 425 434 (Pubitemid 34112296)
42. Sinnwell, J.P., Schaid, D.J., 2005. haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous. R package version 1.2.2. http://mayoresearch.mayo.edu/mayo/research/biostat/schaid.cfm. 2005. Ref Type: Computer Program.
43. H.H. Stassen, R. Bridler, S. Hagele, M. Hergersberg, B. Mehmann, A. Schinzel, M. Weisbrod, and C. Scharfetter Schizophrenia and smoking: evidence for a common neurobiological basis? Am. J. Med. Genet. 96 2000 173 177 (Pubitemid 30180858)
44. S.H. Stephens, J. Logel, A. Barton, A. Franks, J. Schultz, M. Short, J. Dickenson, B. James, T.E. Fingerlin, B. Wagner, C. Hodgkinson, S. Graw, R.G. Ross, R. Freedman, and S. Leonard Association of the 5′-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia Schizophr. Res. 109 2009 102 112
45. W.G. van Gorp, L. Altshuler, D.C. Theberge, J. Wilkins, and W. Dixon Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study Arch. Gen. Psychiatry 55 1998 41 46 (Pubitemid 28069038)
46. J.W. Young, N. Crawford, J.S. Kelly, L.E. Kerr, H.M. Marston, C. Spratt, K. Finlayson, and J. Sharkey Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice Eur. Neuropsychopharmacol. 17 2007 145 155 (Pubitemid 44802833)
47. S. Zammit, G. Spurlock, H. Williams, N. Norton, N. Williams, M.C. O'Donovan, and M.J. Owen Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use Br. J. Psychiatry 191 2007 402 407 (Pubitemid 350069580)
48. L. Zhao, Y.P. Kuo, A.A. George, J.H. Peng, M.S. Purandare, K.M. Schroeder, R.J. Lukas, and J. Wu Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line J. Pharmacol. Exp. Ther. 305 2003 1132 1141 (Pubitemid 36617992)